Simplex Trading, LLC Arca Biopharma, Inc. Transaction History

Simplex Trading, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$1.71 - $4.0 $465 - $1,088	272 Added 9066.67%	275 $1,000
Q1 2024 Apr 25, 2024	SELL	$1.58 - $1.78 $153 - $172	-97 Reduced 97.0%	3 $0
Q4 2023 Feb 02, 2024	BUY	$1.7 - $2.05 $170 - $204	100 New	100 $0
Q3 2022 Nov 04, 2022	BUY	$2.13 - $25.68 $1,101 - $13,276	517 New	517 $1,000
Q2 2022 Aug 03, 2022	SELL	$2.2 - $2.53 $5,728 - $6,588	-2,604 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$1.77 - $2.49 $22,268 - $31,326	-12,581 Reduced 82.85%	2,604 $5,000
Q4 2021 Feb 23, 2022	BUY	$2.15 - $2.97 $29,917 - $41,327	13,915 Added 1095.67%	15,185 $32,000
Q3 2021 Oct 28, 2021	BUY	$2.77 - $3.74 $3,517 - $4,749	1,270 New	1,270 $4,000
Q2 2021 Aug 12, 2021	SELL	$3.06 - $3.9 $34,030 - $43,371	-11,121 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$3.48 - $5.3 $37,479 - $57,081	10,770 Added 3068.38%	11,121 $40,000
Q4 2020 Feb 02, 2021	BUY	$3.74 - $5.18 $1,312 - $1,818	351 New	351 $1,000

280K

Ticker ABIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,410,100
Description
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.